Rasilez Hct



Indications and Reactions:

Role Indications Reactions
Primary
Hypertension 68.2%
Diabetes Mellitus 6.8%
Type 2 Diabetes Mellitus 2.3%
Atrial Fibrillation 2.2%
Depression 2.2%
Hyperlipidaemia 1.8%
Hyperuricaemia 1.8%
Hypercholesterolaemia 1.7%
Chronic Obstructive Pulmonary Disease 1.5%
Cardiac Failure 1.3%
Hypothyroidism 1.3%
Blood Cholesterol Increased 1.2%
Gastrooesophageal Reflux Disease 1.2%
Sleep Disorder 1.2%
Affective Disorder 1.0%
Pulmonary Arterial Hypertension 1.0%
Arrhythmia 0.8%
Arteriosclerosis 0.8%
Cardiovascular Disorder 0.8%
Cerebrovascular Accident 0.8%
Syncope 9.4%
Blood Pressure Increased 8.7%
Death 7.9%
Hyponatraemia 7.1%
Renal Failure 7.1%
Atrial Fibrillation 6.3%
Renal Failure Acute 6.3%
Drug Ineffective 4.7%
Hypertension 4.7%
Dyspnoea 3.9%
Malaise 3.9%
Muscular Weakness 3.9%
Myocardial Infarction 3.9%
Transient Ischaemic Attack 3.9%
Cerebrovascular Accident 3.1%
Diarrhoea 3.1%
Loss Of Consciousness 3.1%
Oedema 3.1%
Vomiting 3.1%
Cardiac Arrest 2.4%
Secondary
Hypertension 63.6%
Diabetes Mellitus 8.9%
Depression 4.1%
Heart Rate 2.7%
Benign Prostatic Hyperplasia 1.8%
Blood Pressure Increased 1.8%
Renin Increased 1.8%
Hypercholesterolaemia 1.6%
Hyperuricaemia 1.6%
Intervertebral Disc Disorder 1.6%
Affective Disorder 1.4%
Essential Hypertension 1.1%
Gastrooesophageal Reflux Disease 1.1%
Hyperlipidaemia 1.1%
Prophylaxis Against Gastrointestinal Ulcer 1.1%
Anxiety 0.9%
Arteriosclerosis Coronary Artery 0.9%
Bone Pain 0.9%
Cardiac Failure 0.9%
Chronic Obstructive Pulmonary Disease 0.9%
Cerebrovascular Accident 9.0%
Blood Pressure Increased 7.5%
Hepatitis Cholestatic 6.0%
Hyponatraemia 6.0%
Malaise 6.0%
Pancreatitis Acute 6.0%
Rash 6.0%
Renal Failure Acute 6.0%
Vision Blurred 6.0%
Acute Myocardial Infarction 4.5%
Dyspnoea 4.5%
Fatigue 4.5%
Hypertension 4.5%
Syncope 4.5%
Urinary Tract Infection 4.5%
Benign Prostatic Hyperplasia 3.0%
Condition Aggravated 3.0%
Diabetes Mellitus 3.0%
Fluid Overload 3.0%
Gait Disturbance 3.0%
Concomitant
Hypertension 26.1%
Premedication 13.0%
Computerised Tomogram 6.5%
Depression 6.5%
Type 2 Diabetes Mellitus 6.5%
Bronchopulmonary Disease 4.3%
Cardiac Disorder 4.3%
Diabetes Mellitus 4.3%
Erectile Dysfunction 4.3%
Angina Pectoris 2.2%
Anxiety 2.2%
Blood Cholesterol Abnormal 2.2%
Blood Disorder 2.2%
Blood Potassium Decreased 2.2%
Blood Pressure 2.2%
Cardiovascular Event Prophylaxis 2.2%
Chronic Myeloid Leukaemia 2.2%
Diuretic Therapy 2.2%
Gastrooesophageal Reflux Disease 2.2%
Gout 2.2%
Dyspnoea 12.5%
Thrombocytopenia 12.5%
Cardiac Valve Disease 6.3%
Colitis 6.3%
Dehydration 6.3%
Gamma-glutamyltransferase Increased 6.3%
Headache 6.3%
Heart Rate Decreased 6.3%
Hepatic Failure 6.3%
Peripheral Ischaemia 6.3%
Pruritus Generalised 6.3%
Scrotal Haematoma 6.3%
Urinary Retention 6.3%
Urticaria 6.3%
Interacting
Hypertension 50.0%
Intervertebral Disc Disorder 15.4%
Myocardial Ischaemia 15.4%
Atrial Fibrillation 7.7%
Prophylaxis Against Gastrointestinal Ulcer 7.7%
Hypercholesterolaemia 3.8%
Atrial Fibrillation 14.3%
Hepatitis Cholestatic 14.3%
Phosphenes 14.3%
Sudden Death 14.3%
Varicose Ulceration 14.3%
Vision Blurred 14.3%
Yellow Skin 14.3%